Dudediligence.

Kodiak Sciences Inc

KODNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$43.9MSep ’24−$44.1MDec ’24−$57.5MMar ’25−$54.3MJun ’25−$61.5MSep ’25−$56.7MDec ’25−$58.2MMar ’26−$65.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$267.1M−$341.4M−$277.3M−$186.8M−$234.4M
Net income−$267.0M−$333.8M−$260.5M−$176.2M−$230.0M
Operating cash flow−$182.3M−$206.5M−$154.2M−$117.3M−$136.0M
Free cash flow−$199.3M−$243.5M−$195.5M−$117.7M−$136.5M
Cash$731.5M$190.4M$285.5M$168.1M$209.9M
Shares outstanding51.8M52.3M52.5M52.7M61.8M